Loading stock…

Empyrean Technology Co., Ltd. (301269) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

Empyrean Technology Co., Ltd.

301269Market cap $6.92BPrice $12.6

Country🇨🇳China

SectorTechnology

IndustrySoftware

Builds electronic design automation software that Chinese chipmakers use to design semiconductors, filling a critical gap as Western EDA tools face export restrictions. It's China's answer to Synopsys and Cadence in the chip design software race.

In Bastion Portfolios?

52W Return-27%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+18%9

Revenue Forecast

Rev CAGR (1y)+26%9

Rev CAGR (3y)+24%9

Rev CAGR (5y)+25%10

Earnings Forecast

EPS Growth Y+1+88%10

EPS Growth Y+2+77%10

EPS Growth Y+3+72%10

Quality

Margins

EBIT Margin-8%1

Net Income Margin1%2

Free Cash Flow Margin5%4

Debt

Net Debt/EBITDAna–

Efficiency

ROE0%2

ROA0%2

Earnings Stability44

GEAR+WEAK24

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)3351

P/E Ratio (Forward 3y)1411

P/BV9.02

EV Multiples

EV/EBITDA Fwd1011

EV/EBIT Fwd1831

Yield

Free Cash Flow Yield0.1%3

Dividend Yield0.2%1

Momentum

Short term

1 month return-9%3

3 month return-29%1

YTD return-20%2

Mid term

Price vs 52wHigh58%2

1 year return-33%2

Long term

3 year return-19%2

5 year return+14%4

Risk Shield

Price Risk

Beta0.58

Volatility56%2

Free Cash Flow

Free Cash Flow Margin5%4

Free Cash Flow Yield0.1%3

Quality

ROCE-2%1

Earnings Stability44

Net Debt/EBITDAna–

02Growth

Is it actually growing, and how fast?

301269Empyrean Technology Co.

Revenue FY25$189M

GROWTH RATING↗

VERY STRONG96 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+18%9

Revenue, next 1Y+26%9

Revenue, next 3Y, CAGR+24%9

Revenue, next 5Y, CAGR+25%10

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+88%10

EPS growth, FY27E+77%10

EPS growth, FY28E+72%10

GROWTH ASSESSMENT

STRENGTHS

It out-grows 96% of companies worldwide.

Revenue grew 18%/yr over the last 3 years, ahead of 80% of companies worldwide.9/10

Revenue is set to grow 24%/yr over the next 3 years, ahead of most of the market.9/10

Revenue grew 18%/yr over the last 3 years and is set to grow 24%/yr from here.

The runway holds up: revenue is set to grow 25%/yr over five years.10/10

Earnings are set to grow faster than sales (EPS about 77%/yr vs revenue 24%/yr), so margins should widen.

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Hyper Compounder

A top-tier grower that's speeding up.

03Price Momentum

Is the market behind it right now?

301269Empyrean Technology Co.

Total return Current−2.9%

Price return Current−3.3%

MOMENTUM RATING↗

VERY WEAK7 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-9%3

3-month return-29%1

YTD return-20%2

MID & LONG-TERM▾SCORE

% of 52-week high58%2

1-year return-33%2

3-year return-19%2

5-year return+14%4

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-19% over three years and +14% over five), behind 70% of the market.

It's down 33% over the past year, now 42% below its 52-week high. That is lagging the market.

The stock is underperforming over the past month (-9%), over three months (-29%) and so far this year (-20%).

BOTTOM LINE

Falling Knife

Returns rank poorly over both the short and long run, and the price is still falling. Momentum is firmly negative — catching this is a bet against the tape, not with it. Wait for a base to form. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Empyrean Tech. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

301269Empyrean Technology Co.

Revenue FY25$189M

GROWTH RATING↗

VERY STRONG96 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+18%9

Revenue, next 1Y+26%9

Revenue, next 3Y, CAGR+24%9

Revenue, next 5Y, CAGR+25%10

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+88%10

EPS growth, FY27E+77%10

EPS growth, FY28E+72%10

GROWTH ASSESSMENT

STRENGTHS

It out-grows 96% of companies worldwide.

Revenue grew 18%/yr over the last 3 years, ahead of 80% of companies worldwide.9/10

Revenue is set to grow 24%/yr over the next 3 years, ahead of most of the market.9/10

Revenue grew 18%/yr over the last 3 years and is set to grow 24%/yr from here.

The runway holds up: revenue is set to grow 25%/yr over five years.10/10

Earnings are set to grow faster than sales (EPS about 77%/yr vs revenue 24%/yr), so margins should widen.

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Hyper Compounder

A top-tier grower that's speeding up.

03Price Momentum

Is the market behind it right now?

301269Empyrean Technology Co.

Total return Current−2.9%

Price return Current−3.3%

MOMENTUM RATING↗

VERY WEAK7 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-9%3

3-month return-29%1

YTD return-20%2

MID & LONG-TERM▾SCORE

% of 52-week high58%2

1-year return-33%2

3-year return-19%2

5-year return+14%4

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-19% over three years and +14% over five), behind 70% of the market.

It's down 33% over the past year, now 42% below its 52-week high. That is lagging the market.

The stock is underperforming over the past month (-9%), over three months (-29%) and so far this year (-20%).

BOTTOM LINE

Falling Knife

04Value

Are you paying a fair price for it?

Stop guessing on Empyrean Tech. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community